317 related articles for article (PubMed ID: 30950074)
1. The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors.
Vermeulen M; Sykes W; Coleman C; Custer B; Jacobs G; Jaza J; Kaidarova Z; Hlela C; Gessain A; Cassar O; Poole C; Ingram C; Murphy EL; Reddy R
Vox Sang; 2019 Jul; 114(5):451-458. PubMed ID: 30950074
[TBL] [Abstract][Full Text] [Related]
2. [Determination of anti-HTLV-I/II antibodies: Experience in 28,897 blood donations in Buenos Aires].
Blejer JL; Saguier MC; Salamone HJ; Carreras LA
Sangre (Barc); 1995 Dec; 40(6):447-51. PubMed ID: 8850226
[TBL] [Abstract][Full Text] [Related]
3. Human T-cell lymphotropic virus type I and II seroprevalence among volunteer blood donors in Thailand.
Oota S; Chaiwong K; Pikulsod S; Khuenkaew R; Pheakkhuntod S; Rattajak P; Kramkratok P; Shiu C; Bhatnagar S; Sakuldamrongpanich T
Pathog Glob Health; 2018 Oct; 112(7):343-348. PubMed ID: 30424716
[TBL] [Abstract][Full Text] [Related]
4. Human T-Lymphotropic Virus Type 1 and 2 Seroprevalence among first-time blood donors in Chile, 2011-2013.
San Martín H; Balanda M; Vergara N; Valenzuela MA; Cartier L; Ayala S; Ramírez E
J Med Virol; 2016 Jun; 88(6):1067-75. PubMed ID: 26538335
[TBL] [Abstract][Full Text] [Related]
5. HTLV screening of blood donors using chemiluminescence immunoassay in three major provincial blood centers of China.
Zhao J; Zhao F; Han W; Xu X; Wang L; Li R; Li T; Wu L; Du D; Zeng X; Cui X; Chen Y; Zeng J; Wang L
BMC Infect Dis; 2020 Aug; 20(1):581. PubMed ID: 32762656
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of Human T-Cell Lymphotropic Virus-1/2 in Blood Donors in Northern Pakistan: Implications for Blood Donor Screening.
Niazi SK; Bhatti FA; Salamat N
J Coll Physicians Surg Pak; 2015 Dec; 25(12):874-7. PubMed ID: 26691361
[TBL] [Abstract][Full Text] [Related]
7. Trend in seroprevalence of HTLV-1/2 in Taiwanese blood donors-A 10-year follow-up.
Lee YH; Lu CT; Feng IJ; Hung CM
Transfus Med; 2023 Aug; 33(4):320-328. PubMed ID: 37209036
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.
Chang YB; Kaidarova Z; Hindes D; Bravo M; Kiely N; Kamel H; Dubay D; Hoose B; Murphy EL
J Infect Dis; 2014 Feb; 209(4):523-31. PubMed ID: 24068702
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of human T-cell lymphotropic virus type 1 and 2 in blood donors from the regional hospital of Valdivia, Chile.
Chandía L; Sotomayor C; Ordenes S; Salas P; Navarrete M; Lopez M; Otth C
Med Microbiol Immunol; 2010 Nov; 199(4):341-4. PubMed ID: 20706847
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of human T-lymphotropic virus infection among blood donors in southeast China, 2004-2013.
Xie J; Ge S; Zhang Y; Lin Y; Ni H; Zhang J; Chen C
PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003685. PubMed ID: 25830656
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Human T-lymphotropic virus type 1 and 2 among blood donors in Manaus, Amazonas State, Brazil.
Morais MPE; Gato CM; Maciel LA; Lalwani P; Costa CA; Lalwani JDB
Rev Inst Med Trop Sao Paulo; 2017 Dec; 59():e80. PubMed ID: 29267588
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of anti-HTLV I/II seroprevalence in healthy blood donors in Izmir region, Turkey].
Sertöz R; Turhan A; Bozkurt H; Samlıoğlu P; Değirmenci A; Aydınok Y; Erensoy S
Mikrobiyol Bul; 2010 Oct; 44(4):579-84. PubMed ID: 21063970
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of HTLV-1/2 Among Voluntary Blood Donors in Vietnam.
Pham D; Nguyen D; Nguyen TA; Tran C; Tran L; Devare S; Tran A; Bhatnagar S
AIDS Res Hum Retroviruses; 2019 Apr; 35(4):376-381. PubMed ID: 30565470
[TBL] [Abstract][Full Text] [Related]
14. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil.
Segurado AA; Malaque CM; Sumita LM; Pannuti CS; Lal RB
Am J Trop Med Hyg; 1997 Aug; 57(2):142-8. PubMed ID: 9288805
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence and geographical distribution of human T-lymphotropic virus type 1 among volunteer blood donors in endemic areas of Iran.
Karimi G; Zadsar M; Pourfathollah AA
Virol J; 2017 Jan; 14(1):14. PubMed ID: 28137274
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of human T-lymphotropic virus (HTLV) in blood donors in sub-Saharan Africa: a systematic review and meta-analysis.
Ngoma AM; Omokoko MD; Mutombo PB; Nollet KE; Ohto H
Vox Sang; 2019 Jul; 114(5):413-425. PubMed ID: 30972789
[TBL] [Abstract][Full Text] [Related]
17. Decline in prevalence and asymmetric distribution of human T cell lymphotropic virus 1 and 2 in blood donors, State of Minas Gerais, Brazil, 1993 to 2007.
Dias-Bastos MR; Oliveira CD; Carneiro-Proietti AB
Rev Soc Bras Med Trop; 2010; 43(6):615-9. PubMed ID: 21181009
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
Kwon SY; Lim AH; Park JY; Han SH; Cho NS
J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of human T-cell lymphotropic virus type I/II in Benin (West Africa).
Dumas M; Houinato D; Verdier M; Zohoun T; Josse R; Bonis J; Zohoun I; Massougbodji A; Denis F
AIDS Res Hum Retroviruses; 1991 May; 7(5):447-51. PubMed ID: 1873079
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of HTLV-1/2 in blood donors from Misiones Province].
Malan R; Berini CA; Eirin ME; Delfino CM; Pedrozo W; Krupp R; García Plichta A; Biglione MM
Medicina (B Aires); 2010; 70(1):71-4. PubMed ID: 20228028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
